A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial
J Parkinsons Dis
.
2022;12(1):473.
doi: 10.3233/JPD-219007.
Authors
Giovanni Abbruzzese
1
,
Jaime Kulisevsky
2
,
Bruno Bergmans
3
,
Juan C Gomez-Esteban
4
,
Georg Kägi
5
,
Jason Raw
6
,
Alessandro Stefani
7
,
Tobias Warnecke
8
,
Wolfgang H Jost
9
;
SYNAPSES Study Investigators Group
Affiliations
1
DINOGMI, University of Genoa, Genova, Italy.
2
Sant Pau Hospital, Universitat Aut'onoma de Barcelona, CIBERNED, Barcelona, Spain.
3
Department of Neurology, AZ St-Jan Brugge-Oostende AV, Campus Brugge, Brugge & Ghent University Hospital, Ghent, Belgium.
4
Biocruces Research Institute, Barakaldo, Spain.
5
Department of Neurology, Cantonal Hospital St.Gallen, Switzerland.
6
Fairfield General Hospital, Bury, Greater Manchester, UK.
7
Parkinson Center, University Policlinico Tor Vergata, Roma, Italy.
8
Department of Neurology, University of Muenster, Muenster, Germany.
9
Parkinson-Klinik Ortenau, University of Freiburg, Wolfach, Germany.
PMID:
34275911
PMCID:
PMC8809133
DOI:
10.3233/JPD-219007
No abstract available
Publication types
Published Erratum